<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Acute myocardial infarction and pregnancy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Acute myocardial infarction and pregnancy</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Acute myocardial infarction and pregnancy</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carol A Waksmonski, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anita LaSala, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Guy S Reeder, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Charles J Lockwood, MD, MHCM</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Todd F Dardas, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 17, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Myocardial infarction (MI) is an uncommon event in women of childbearing age. However, as the birth rate for women older than 40 years has increased in recent years in some countries such as the United States, MI in pregnant women may become more common [<a href="#rid1">1</a>]. </p><p>Issues related to acute MI in pregnancy will be reviewed here. Other types of acquired heart disease in pregnancy, such as valvular disease and heart failure, are discussed separately. (See  <a class="medical medical_review" href="/d/html/8148.html" rel="external">"Acquired heart disease and pregnancy"</a> and  <a class="medical medical_review" href="/d/html/3507.html" rel="external">"Management of heart failure during pregnancy"</a>.) </p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Incidence </strong>– In a study analyzing the California State Inpatient Database from 2003 to 2011, the incidence of MI in pregnancy was 6.5 per 100,000 pregnancies (341 cases) [<a href="#rid2">2</a>]. A study from the Nationwide Inpatient Sample of pregnancy discharges between 2000 and 2002 in about 1000 hospitals in the United States showed the incidence was 6.2 in 100,000 pregnancies [<a href="#rid3">3</a>]. It was estimated the risk of MI was increased three- to fourfold compared with nonpregnant women. In a French registry of 6.25 million deliveries, 225 women had a first-time MI; the incidence of MI in pregnancy was 4.34/100,000 person-years [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent1">Possible explanations for the increased rate of MI compared with the study above include regional differences and improved detection due to widespread use of troponin testing. (See  <a class="medical medical_review" href="/d/html/86.html" rel="external">"Troponin testing: Clinical use"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Timing during pregnancy </strong>– In a study using data from the National Inpatient Sample from 2002 to 2014 [<a href="#rid5">5</a>], acute MI occurred in 1 of every 12,400 hospitalizations during pregnancy and postpartum with 20.6 percent occurring antepartum, 23.7 percent during the labor and delivery, and 53.4 percent in the postpartum period.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Temporal trends</strong> – MI in pregnancy may be increasing over time since an earlier study from California of births between 1991 and 2000 showed a lower incidence of 2.8 per 100,000 deliveries [<a href="#rid6">6</a>]. Similarly, a separate national United States study showed that the prevalence of MI in pregnancy did increase over these time periods, even after accounting for age and race/ethnicity [<a href="#rid5">5</a>]. </p><p></p><p class="headingAnchor" id="H3"><span class="h1">RISK FACTORS</span><span class="headingEndMark"> — </span>Many risk factors for acute MI in pregnant women are similar to those in the general population [<a href="#rid2">2,3,6-9</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Older age (age &gt;35 years)</p><p class="bulletIndent1"><span class="glyph">●</span>Black race</p><p class="bulletIndent1"><span class="glyph">●</span>Lower socioeconomic status</p><p class="bulletIndent1"><span class="glyph">●</span>Hypertension </p><p class="bulletIndent1"><span class="glyph">●</span>Diabetes mellitus </p><p class="bulletIndent1"><span class="glyph">●</span>Obesity</p><p class="bulletIndent1"><span class="glyph">●</span>Smoking</p><p class="bulletIndent1"><span class="glyph">●</span>Dyslipidemia</p><p class="bulletIndent1"><span class="glyph">●</span>Substance use (cocaine, amphetamine)</p><p class="bulletIndent1"><span class="glyph">●</span>Treatment for infertility (this is a risk factor for MI due to spontaneous coronary artery dissection) [<a href="#rid10">10</a>].</p><p></p><p>Risk factors for MI in pregnancy (859 cases) were evaluated in the Nationwide Inpatient Sample [<a href="#rid3">3</a>]. Hypertension (odds ratio [OR] 21.7 95% 6.8-69.1), smoking (OR 8.4, 95% CI 5.4-12.9), and diabetes (OR 3.6, 95% CI 1.5-8.3) were associated with an elevated risk of MI. Maternal age categories of 30 to 35, 35 to 39, and &gt;40 years were each associated with increased risk of MI in pregnancy compared with maternal age &lt;20 years (ORs 6.7, 16, and 15.2). Other maternal risk factors shown to be associated with elevated risk of MI in pregnancy were history of thrombophilia (OR 25.6) and pregnancy complications such as blood transfusion (OR 5.1) and postpartum infection (OR 3.2) [<a href="#rid3">3</a>]. </p><p>It is not clear if pregnancy itself is a risk factor for MI. In a report with 3.6 million woman-years of observation, the incidence of a first-ever MI not related to pregnancy was 5 per 100,000 woman-years in women of child-bearing age, with the risk increasing dramatically after age 35 [<a href="#rid11">11</a>]. Since pregnancy lasts three-quarters of a year, this rate of MI is not different from the rates in the two large epidemiologic studies cited above (2.8 to 6.2 per 100,000 pregnancies) [<a href="#rid3">3,6</a>].</p><p>Other risk factors that have been identified include preeclampsia, thrombophilia, transfusion, postpartum infections, cocaine use, and multiparity [<a href="#rid3">3,6</a>]. </p><p class="headingAnchor" id="H155062428"><span class="h1">ETIOLOGY</span><span class="headingEndMark"> — </span>Two studies of over 100 pregnant women have evaluated the causes of myocardial infarction using findings at the time of coronary angiography or autopsy and found atherosclerosis to be the direct cause less often than in the general population (see  <a class="medical medical_review" href="/d/html/115790.html" rel="external">"Mechanisms of acute coronary syndromes related to atherosclerosis"</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>In a review of 103 cases (1995 to 2005), coronary atherosclerosis (with or without) intracoronary thrombus was present in only 40 percent [<a href="#rid12">12</a>]. The remaining cases consisted of coronary artery dissection (27 percent), thrombus in a normal coronary artery (8 percent), coronary artery spasm (2 percent), emboli (2 percent), and normal coronary arteries (13 percent). Most cases occur in the anterior wall [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a study of 129 cases (2006 to 2011), coronary atherosclerosis was found in 27 percent [<a href="#rid9">9</a>]. The remaining cases included coronary dissection (43 percent), thrombus in a normal coronary artery (17 percent), coronary artery spasm (2 percent), and normal coronary anatomy (11 percent). Three patients were ultimately diagnosed with takotsubo cardiomyopathy.</p><p></p><p>These two studies found a relatively high incidence of coronary artery dissection. (See  <a class="medical medical_review" href="/d/html/1467.html" rel="external">"Clinical features and diagnosis of coronary heart disease in women", section on 'Role of coronary angiography'</a>.) </p><p>It has been suggested that arterial dissection during or early after pregnancy is related to structural changes in the intima and media of the arterial wall that are produced by hormonal and hemodynamic changes [<a href="#rid11">11,13</a>]. Although dissection can occur in the absence of risk factors, it may occur more frequently in conditions associated with hypertension that independently damage the arterial wall. </p><p>In one study, 15 percent of all acute MIs were from coronary artery dissection (note that all patients did not have coronary angiography) [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/d/html/97665.html" rel="external">"Spontaneous coronary artery dissection"</a>.)</p><p>In a report of 120 cases of pregnancy-associated spontaneous coronary artery dissections, 72 percent had left anterior descending coronary artery involvement, 36 percent had left main coronary artery involvement, and 40 percent had multivessel involvement. Maternal complications included cardiogenic shock (24 percent), requirement for mechanical support (28 percent), and need for urgent coronary artery bypass graft surgery (27.5 percent). The maternal mortality was 4 percent, and the fatal mortality was 2.5 percent [<a href="#rid14">14</a>].</p><p>The American Heart Association has published a scientific statement on spontaneous coronary artery dissection, providing guidelines for management [<a href="#rid10">10</a>].</p><p class="headingAnchor" id="H155062107"><span class="h1">CLINICAL PRESENTATION</span><span class="headingEndMark"> — </span>In many cases, pregnant women with acute myocardial infarction (MI) present with symptoms and signs similar to the general population. In brief, patients often complain of the development (over the course of minutes) of chest discomfort that is felt in the anterior chest or epigastric area and often with radiation to the shoulders, arms, jaws, or back. Shortness of breath and nausea may also be present. (See  <a class="medical medical_review" href="/d/html/184.html" rel="external">"Initial evaluation and management of suspected acute coronary syndrome (myocardial infarction, unstable angina) in the emergency department", section on 'Clinical presentation'</a>.)</p><p>However, there is some evidence that women more often present with atypical features such as dyspnea or nausea without chest discomfort, palpitations, syncope, or cardiac arrest. (See  <a class="medical medical_review" href="/d/html/50.html" rel="external">"Coronary artery disease and myocardial infarction in young people", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/1467.html" rel="external">"Clinical features and diagnosis of coronary heart disease in women", section on 'Symptoms of ischemia'</a>.) It is not known whether pregnancy influences the clinical characteristics of the presentation of MI. </p><p>A 2014 study of 134 cases identified by literature search and 16 unpublished cases made the following observations [<a href="#rid9">9</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Approximately three-quarters of women presented with ST-elevation MI (STEMI) and one-quarter with non-ST elevation MI (NSTEMI). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For both STEMI and NSTEMI, about half of the cases occurred after delivery; for the remainder, the frequency increased with each trimester. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The MI was anterior in location in 69 percent, inferior in 27 percent, and lateral in 4 percent</p><p></p><p>In one study, 42.4 percent of the cases were ST-elevation MIs and 57.6 percent of the cases were non-ST elevation MIs [<a href="#rid5">5</a>]. </p><p>For patients with coronary artery dissection, takotsubo cardiomyopathy, or coronary artery spasm (see <a class="local">'Etiology'</a> above), which are uncommon causes of acute MI in the general population, the clinical presentation will differ somewhat from the classic presentation of acute MI secondary to atherothrombotic disease. (See  <a class="medical medical_review" href="/d/html/3494.html" rel="external">"Clinical manifestations and diagnosis of stress (takotsubo) cardiomyopathy", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/1481.html" rel="external">"Vasospastic angina", section on 'Clinical presentation'</a> and  <a class="medical medical_review" href="/d/html/1467.html" rel="external">"Clinical features and diagnosis of coronary heart disease in women", section on 'Role of coronary angiography'</a>.) </p><p class="headingAnchor" id="H5"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of acute myocardial infarction (MI) associated with pregnancy is guided by the same principles as in the general population, including ischemic symptoms (eg, anginal chest pain), electrocardiographic (ECG) abnormalities, and elevations in cardiac biomarkers [<a href="#rid15">15</a>]. In terms of cardiac biomarkers, troponins are preferred to creatine kinase MB fraction [<a href="#rid16">16</a>]. (See  <a class="medical medical_review" href="/d/html/52.html" rel="external">"Diagnosis of acute myocardial infarction"</a>.)</p><p>Specifically, acute MI is present when there is a rise and/or fall of cardiac troponin and the presence of one of the following: ischemic symptoms; new Q waves, significant ST-segment-T wave changes, or new left bundle branch block on the ECG; or intracoronary thrombus on angiography.</p><p class="headingAnchor" id="H155062158"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Similar to the general population, another diagnosis may be present in a pregnant woman who presents with symptoms and signs of acute myocardial infarction. Acute pulmonary embolism, aortic dissection, musculoskeletal pain, and gastroesophageal reflux disease should be considered.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/89374.html" rel="external">"Pulmonary embolism in pregnancy: Clinical presentation and diagnosis", section on 'Clinical presentation'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/4788.html" rel="external">"Maternal adaptations to pregnancy: Dyspnea and other physiologic respiratory changes", section on 'Approach to differential diagnosis'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2265.html" rel="external">"Clinical manifestations and diagnosis of gastroesophageal reflux in adults"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/8190.html" rel="external">"Clinical features and diagnosis of acute aortic dissection", section on 'High-risk conditions'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/427.html" rel="external">"Maternal adaptations to pregnancy: Musculoskeletal changes and pain", section on 'Chest wall pain'</a>.)</p><p></p><p>The HELLP syndrome, preeclampsia, and acute fatty liver of pregnancy commonly present with severe epigastric pain.<strong> </strong>(See  <a class="medical medical_review" href="/d/html/6778.html" rel="external">"HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets)", section on 'Patient presentation'</a> and  <a class="medical medical_review" href="/d/html/6814.html" rel="external">"Preeclampsia: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/3619.html" rel="external">"Acute fatty liver of pregnancy"</a>.)</p><p class="headingAnchor" id="H155061996"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>In general, the management of acute MI in pregnant women is similar to that in the general population. However, there are also unique considerations in pregnant women with acute MI given that many of the appropriate diagnostic and therapeutic interventions may pose a risk to the fetus.</p><p class="headingAnchor" id="H1156342859"><span class="h2">General strategy and principles</span><span class="headingEndMark"> — </span>Due to the potential risks of myocardial infarction and its treatment, care should be individualized and involve the highly coordinated efforts of emergency, obstetric/maternal fetal medicine, and cardiovascular healthcare teams. For patients managed in an emergency department setting, immediate consultation of the last two should be requested.</p><p>In general, the management of acute myocardial infarction (MI) in pregnant women is similar to that in the general population, including the use of revascularization with percutaneous coronary intervention and stenting or coronary artery bypass graft surgery in patients with fixed coronary artery stenoses [<a href="#rid3">3,15,17-20</a>] (see  <a class="medical medical_review" href="/d/html/66.html" rel="external">"Overview of the acute management of ST-elevation myocardial infarction"</a> and  <a class="medical medical_review" href="/d/html/68.html" rel="external">"Overview of the acute management of non-ST-elevation acute coronary syndromes"</a>). However, as mentioned above, less than fifty percent of cases are attributable to atherosclerotic lesions. (See <a class="local">'Etiology'</a> above.)</p><p>The therapeutic strategy will depend on the etiology of the MI and the stage of pregnancy in which it occurs. For women with a coronary dissection, conservative therapy is recommended, although the optimal management is uncertain. (See  <a class="medical medical_review" href="/d/html/97665.html" rel="external">"Spontaneous coronary artery dissection"</a>.) </p><p>In some cases, the mechanism will appear to be primarily thrombus obstruction. Thrombus aspiration and balloon angioplasty should be performed and stenting reserved as bailout. </p><p>For pregnant women with MI thought secondary to atherosclerotic obstruction, the optimal use of stents and antiplatelet therapy has not been well studied. The following is our approach in those undergoing stenting: </p><p class="bulletIndent1"><span class="glyph">●</span>Most of our experts choose current (newer) generation drug-eluting stents rather than bare metal stents, although their safety in neonates is not known. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We treat with at least one month of dual antiplatelet therapy with <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> and <a class="drug drug_general" data-topicid="8921" href="/d/drug information/8921.html" rel="external">clopidogrel</a> (see  <a class="medical medical_review" href="/d/html/1569.html" rel="external">"Percutaneous coronary intervention with intracoronary stents: Overview"</a>). A longer duration of clopidogrel (up to three months) may be reasonable in patients at high risk of recurrent ischemia and reasonable bleeding risk. If delivery occurs within that time frame, the obstetrical and anesthesia team should be aware of and prepared to treat an increased bleeding risk. Aspirin is continued indefinitely.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Heparin is not a substitute for dual antiplatelet therapy as it has not been shown to prevent stent thrombosis. </p><p></p><p>For some women who have moved beyond the acute phase of an MI, optimal care may include a decision to postpone delivery, perhaps up to two to three weeks after an acute MI [<a href="#rid21">21</a>]. However, there are no clinical trials that have prospectively evaluated the optimal timing of surgical procedures or labor and delivery after an acute (one to seven days) or recent (7 to 30 days) MI, especially in the current era of cardiac therapies and modern anesthesia. </p><p>Measures should be taken to minimize the cardiac workload at the time of delivery. These include epidural anesthesia, supplemental oxygen, left lateral position, treatment of hypertension and tachycardia, and either an instrumental vaginal delivery or cesarean birth (in unstable cases or for the usual obstetric indications) [<a href="#rid8">8</a>]. The goal heart rate and blood pressure in patients with acute MI is discussed separately. (See  <a class="medical medical_review" href="/d/html/96.html" rel="external">"Acute myocardial infarction: Role of beta blocker therapy", section on 'Heart rate goal'</a> and  <a class="medical medical_review" href="/d/html/3861.html" rel="external">"Goal blood pressure in adults with hypertension"</a>.)</p><p>General issues related to labor and delivery in women with underlying heart disease are discussed separately. (See  <a class="medical medical_review" href="/d/html/8148.html" rel="external">"Acquired heart disease and pregnancy", section on 'Management of labor and delivery'</a>.) </p><p class="headingAnchor" id="H98744421"><span class="h2">Protecting the fetus</span><span class="headingEndMark"> — </span>The fetus should be closely monitored by standard obstetrical protocols with a plan for delivery if there is sudden maternal or fetal deterioration. In the event of maternal cardiac arrest, the best prognosis for the fetus occurs when delivery is within four to five minutes. Delivery may also aid maternal resuscitative efforts. (See  <a class="medical medical_review" href="/d/html/14184.html" rel="external">"Sudden cardiac arrest and death in pregnancy"</a>.)</p><p>There are also unique considerations in pregnant women with acute MI given that many of the appropriate diagnostic and therapeutic interventions may pose a risk to the fetus.</p><p class="headingAnchor" id="H3844180896"><span class="h3">Radiation</span><span class="headingEndMark"> — </span>Ionizing radiation is needed for catheter-based diagnosis and treatment of acute MI. The risk of radiation to the fetus should be taken into account. However, concern about the possible effects of ionizing radiation should not prevent medically indicated diagnostic procedures using the best available modality for the clinical situation. When procedures requiring ionizing radiation are necessary, various techniques can be employed to minimize the radiation dose. (See  <a class="medical medical_review" href="/d/html/4791.html" rel="external">"Diagnostic imaging in pregnant and lactating patients", section on 'Summary and recommendations'</a>.)</p><p class="headingAnchor" id="H114037012"><span class="h3">Medications</span><span class="headingEndMark"> — </span>A study provides a comprehensive review of medications for cardiovascular disease during pregnancy [<a href="#rid22">22</a>]. We provide a more abbreviated review of commonly used and/or considered medications for acute MI during pregnancy.   </p><p>The following medications appear to be generally safe in pregnancy:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">Aspirin</a> – Low-dose aspirin (75 to 162 mg/day) appears to be safe in pregnancy when given after the first trimester [<a href="#rid23">23,24</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nitrates</strong> – Intravenous, transdermal, and oral nitrates have been used during pregnancy for both obstetric and medical indications without apparent harmful effects, although maternal hypotension should be avoided [<a href="#rid25">25</a>]. (See  <a class="medical medical_review" href="/d/html/64.html" rel="external">"Nitrates in the management of acute coronary syndrome"</a> and  <a class="medical medical_review" href="/d/html/1549.html" rel="external">"Nitrates in the management of chronic coronary syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Beta blockers</strong> – Beta blockers are generally safe for pregnant women. A study using the Kaiser database showed that beta blocker use in pregnancy was not associated with an increased risk of fatal congenital cardiac anomalies [<a href="#rid26">26</a>]. However, occasional cases of small-for-gestational-age infants and neonatal hypoglycemia, respiratory depression, and bradycardia have been reported after prolonged maternal administration of beta blockers, particularly with <a class="drug drug_general" data-topicid="8940" href="/d/drug information/8940.html" rel="external">atenolol</a> [<a href="#rid27">27,28</a>]. <a class="drug drug_general" data-topicid="9540" href="/d/drug information/9540.html" rel="external">Labetalol</a> may be the preferred beta blocker. (See  <a class="medical medical_review" href="/d/html/6815.html" rel="external">"Treatment of hypertension in pregnant and postpartum patients"</a>.)</p><p></p><p>The safety of the following medications during pregnancy is less well established:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>P2Y</strong><strong><sub>12 </sub></strong><strong>receptor blocker – </strong>All patients with recent acute coronary syndrome are treated with a platelet P2Y<sub>12 </sub>receptor blocker (<a class="drug drug_general" data-topicid="8921" href="/d/drug information/8921.html" rel="external">clopidogrel</a>, <a class="drug drug_general" data-topicid="9533" href="/d/drug information/9533.html" rel="external">prasugrel</a>, or <a class="drug drug_general" data-topicid="16784" href="/d/drug information/16784.html" rel="external">ticagrelor</a>). The safety of these agents in pregnancy has not been established. </p><p></p><p class="bulletIndent1">In addition, the combination of a P2Y<sub>12</sub> receptor blocker and <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> might increase bleeding at the time of delivery.</p><p></p><p class="bulletIndent1">For patients receiving <a class="drug drug_general" data-topicid="8921" href="/d/drug information/8921.html" rel="external">clopidogrel</a>, we and others recommend holding clopidogrel for seven days before a scheduled delivery [<a href="#rid29">29</a>].</p><p></p><p class="bulletIndent1">A systematic review of antiplatelet therapy in pregnancy examined outcomes for both mothers and neonates when exposed to <a class="drug drug_general" data-topicid="8921" href="/d/drug information/8921.html" rel="external">clopidogrel</a> at varying durations during gestation and did not suggest higher-than-acceptable risk [<a href="#rid30">30</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Anticoagulation</strong> – Heparin does not cross the placenta and thus does not affect the fetus directly. For women who are anticoagulated with heparin for days, weeks, or even months, pregnancy complications associated with bleeding (eg, threatened miscarriage, placenta previa, abruptio placenta) and delivery are more problematic. In such patients, antepartum heparin may have to be discontinued until the bleeding has resolved. In addition, heparin should be discontinued before or during labor to minimize maternal bleeding complications and allow neuraxial anesthesia. (See  <a class="medical medical_review" href="/d/html/1342.html" rel="external">"Use of anticoagulants during pregnancy and postpartum", section on 'Labor and delivery'</a>.)</p><p></p><p class="bulletIndent1">However, with the short-term use of heparin, particularly when used during percutaneous coronary intervention for the treatment of acute MI, its benefit likely outweighs the risk of maternal bleeding complications. For the rare cases of a pregnant woman with a history of heparin-induced thrombocytopenia (HIT) who presents with acute MI, the optimal anticoagulant strategy is not known. While <a class="drug drug_general" data-topicid="8792" href="/d/drug information/8792.html" rel="external">bivalirudin</a> is often preferred to <a class="drug drug_general" data-topicid="8691" href="/d/drug information/8691.html" rel="external">fondaparinux</a> in non-pregnant individuals with HIT who sustain acute MI, these agents are generally avoided during pregnancy. Our contributors have differing approaches to the choice of anticoagulant in pregnant women with HIT, with some preferring fondaparinux and some bivalirudin. A review of the use of factor Xa inhibitors is available [<a href="#rid29">29</a>]. (See  <a class="medical medical_review" href="/d/html/1342.html" rel="external">"Use of anticoagulants during pregnancy and postpartum", section on 'Already taking a DOAC'</a> and  <a class="medical medical_review" href="/d/html/92.html" rel="external">"Acute ST-elevation myocardial infarction: Management of anticoagulation", section on 'Summary and recommendations'</a> and  <a class="medical medical_review" href="/d/html/93.html" rel="external">"Anticoagulant therapy in non-ST elevation acute coronary syndromes", section on 'Summary and recommendations'</a> and  <a class="medical medical_review" href="/d/html/90261.html" rel="external">"Clinical presentation and diagnosis of heparin-induced thrombocytopenia"</a>.)</p><p></p><p>These medications are contraindicated in pregnancy: </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Statins</strong> – Statins are also contraindicated because of lack of information on safety and because cholesterol biosynthesis may be important in fetal development. However, recommendations may change in the future for the use of statins [<a href="#rid31">31</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Angiotensin converting enzyme (ACE) inhibitors and statins</strong> – ACE inhibitors and angiotensin II receptor blockers are teratogenic and thus contraindicated in pregnancy [<a href="#rid32">32</a>]. (See  <a class="medical medical_review" href="/d/html/4789.html" rel="external">"Adverse effects of angiotensin converting enzyme inhibitors and receptor blockers in pregnancy"</a> and  <a class="medical medical_review" href="/d/html/4564.html" rel="external">"Statins: Actions, side effects, and administration", section on 'Risks in pregnancy and breastfeeding'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vasoactive drugs </strong>–<strong> </strong>Drugs that can cause coronary vasoconstriction such as methergine and prostaglandin should be avoided.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fibrinolytic therapy</strong> – There are no controlled studies examining the efficacy and safety of fibrinolytic therapy for acute ST-elevation MI in pregnancy [<a href="#rid33">33,34</a>]. Its use is considered relatively contraindicated. Although teratogenicity has not been reported, the reported risk of maternal hemorrhage is about 8 percent [<a href="#rid35">35</a>]. The risk of puerperal hemorrhage appears to be confined to women treated within eight hours of delivery, although some women have been safely treated, most with disorders other than acute MI [<a href="#rid34">34,36-38</a>]. The risk of bleeding may also be higher after cesarean than vaginal delivery. (See  <a class="medical medical_review" href="/d/html/55.html" rel="external">"Acute ST-elevation myocardial infarction: The use of fibrinolytic therapy"</a>.) </p><p></p><p class="headingAnchor" id="H155062606"><span class="h1">COMPLICATIONS</span><span class="headingEndMark"> — </span>In a study of over 100 cases of MI in pregnant women, the rates of complications were as follows [<a href="#rid9">9</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Heart failure or cardiogenic shock in 38 percent</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Ventricular arrhythmias in 12 percent</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Recurrent angina or MI in 20 percent</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Left ventricular ejection fraction ≤40 percent in 64 percent, ≤30 percent in 24 percent, and ≤20 percent in 9 percent. </p><p></p><p class="headingAnchor" id="H8"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>The in-hospital maternal mortality from MI was between 4.5 and 7 percent in published studies [<a href="#rid3">3,5,6,9</a>]. In a study of women with MI in pregnancy from the California State Inpatient Database from 2003 to 2011, inpatient maternal mortality was 7 percent, and the infant mortality rate was 3.5 percent [<a href="#rid2">2</a>]. A study from the National Inpatient Sample from 2002 to 2014 showed that the maternal mortality rate for MI was 4.5 percent [<a href="#rid5">5</a>].</p><p>The highest risk for maternal death exists when MI occurs in the late third trimester [<a href="#rid6">6,8</a>]. During labor, further cardiac ischemia and decompensation can develop because cardiac demands are maximal at a time when myocardial healing is incomplete. (See  <a class="medical medical_review" href="/d/html/443.html" rel="external">"Maternal adaptations to pregnancy: Cardiovascular and hemodynamic changes", section on 'Intrapartum changes'</a>.)</p><p class="headingAnchor" id="H98744059"><span class="h1">REMOTE MYOCARDIAL INFARCTION</span><span class="headingEndMark"> — </span>There is little information available regarding the risk of subsequent pregnancy in women with a prior history of MI [<a href="#rid8">8,39-41</a>]. People who have received mantle radiation years before their pregnancy may have underlying coronary artery disease that could manifest during pregnancy. About 10 percent of patients will develop significant coronary artery disease, including ostial coronary disease [<a href="#rid42">42</a>]. Counseling women with underlying coronary artery disease is based upon a thorough evaluation of their cardiac status, particularly left ventricular function, ongoing myocardial ischemia, and underlying coronary anatomy. Pre-pregnancy stress testing for women with known coronary disease or women who might be at high risk (prior radiation, etc) is recommended. Changes in the patient's chronic medical regimen would include cessation of angiotensin converting enzyme inhibitors and statins, which are currently contraindicated in pregnancy.</p><p>In a study examining the outcome of pregnancies in women with pre-existing coronary artery disease or acute coronary syndromes (ACS), there were relatively high rates of cardiovascular events during pregnancy (10 percent had an arrhythmia, ACS/MI, heart failure, or angina) as well as a high risk of adverse obstetric (16 percent) and fetal/neonatal complications (30 percent) [<a href="#rid43">43</a>].</p><p class="headingAnchor" id="H24951706"><span class="h1">RECOMMENDATIONS OF OTHERS</span><span class="headingEndMark"> — </span>We agree with the following specific recommendations made in the 2018 European Society of Cardiology guideline for the management of cardiovascular diseases during pregnancy [<a href="#rid44">44</a>] and American Heart Association Scientific Statement on Cardiovascular Considerations in Caring for Pregnant patients [<a href="#rid45">45</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>An ECG and troponin level(s) should be performed in pregnant women with chest pain. If the ECG is nondiagnostic, an echocardiogram may be helpful. (See  <a class="medical medical_review" href="/d/html/52.html" rel="external">"Diagnosis of acute myocardial infarction"</a> and  <a class="medical medical_review" href="/d/html/184.html" rel="external">"Initial evaluation and management of suspected acute coronary syndrome (myocardial infarction, unstable angina) in the emergency department"</a>.) </p><p></p><p class="bulletIndent1">We believe this is a reasonable approach when the managing physicians have a concern that the chest pain is potentially ischemic in origin. Many pregnant women have symptoms of chest pain, but gastroesophageal reflux disease is often the cause.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Primary percutaneous coronary intervention is recommended as the preferred reperfusion therapy for STEMI in pregnancy. (See  <a class="medical medical_review" href="/d/html/15358.html" rel="external">"Primary percutaneous coronary intervention in acute ST-elevation myocardial infarction: Periprocedural management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Conservative management should be considered for stable non-ST-elevation ACS with low-risk criteria during pregnancy. (See  <a class="medical medical_review" href="/d/html/76.html" rel="external">"Risk stratification after non-ST elevation acute coronary syndrome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Angiography is the gold standard for the diagnosis of ischemic heart disease in pregnancy. Fetal radiation protection and radiation reduction measures should be implemented.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An invasive approach is recommended for patients with STEMI and for patients with NSTEMI who are unstable or have a high atherosclerotic burden. Stable patients at low risk can be managed conservatively.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Conservative management is recommended for those found to have pregnancy-related spontaneous coronary artery dissection. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Antiplatelet agents (low-dose <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> and <a class="drug drug_general" data-topicid="8921" href="/d/drug information/8921.html" rel="external">clopidogrel</a>) combined with beta blockers represent the most accepted regimen.</p><p></p><p class="headingAnchor" id="H3666494958"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/118887.html" rel="external">"Society guideline links: Management of cardiovascular diseases during pregnancy"</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis </strong>– The diagnosis and management of acute myocardial infarction (MI) in pregnant women is guided by the same principles as in the general population. (See <a class="local">'Diagnosis'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Team-based care </strong>– In order to negotiate the potential conflicting needs of the mother and fetus, care should be highly coordinated among the emergency, obstetric, and cardiovascular teams.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Close fetal monitoring </strong>– The fetus should be closely monitored. There should be a plan for delivery if there is sudden maternal or fetal deterioration.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management </strong>–<strong> </strong>The management of acute MI in pregnant women is guided by the same general principles as in the general population. However, some medications used during MI in the general population should be used with extra caution or are contraindicated during pregnancy. (See <a class="local">'Management'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Low-dose <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> (75 to 162 mg/day), beta blockers, and nitrates have been used during pregnancy without apparent harmful effects. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cardiac catheterization and possible percutaneous coronary intervention are recommended for high-risk patients (ST-elevation MI). Fibrinolytic therapy is relatively contraindicated. When procedures requiring ionizing radiation are necessary, various techniques can be employed to minimize the radiation dose. (See  <a class="medical medical_review" href="/d/html/4791.html" rel="external">"Diagnostic imaging in pregnant and lactating patients", section on 'Summary and recommendations'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Heparin does not cross the placenta and thus does not affect the fetus directly. However, pregnancy complications associated with bleeding (eg, threatened miscarriage, placenta previa, abruptio placenta) are more problematic in a person who is anticoagulated<strong>.</strong></p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Medications that are contraindicated or should be avoided </strong>–<strong> </strong>Angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and statins are contraindicated in pregnancy. Drugs that can cause coronary vasoconstriction such as methergine and prostaglandin should be avoided after myocardial infarction.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Kochanek KD, Kirmeyer SE, Martin JA, et al. Annual summary of vital statistics: 2009. Pediatrics 2012; 129:338.</a></li><li><a class="nounderline abstract_t">Jalnapurkar S, Xu KH, Zhang Z, et al. Changing Incidence and Mechanism of Pregnancy-Associated Myocardial Infarction in the State of California. J Am Heart Assoc 2021; 10:e021056.</a></li><li><a class="nounderline abstract_t">James AH, Jamison MG, Biswas MS, et al. Acute myocardial infarction in pregnancy: a United States population-based study. Circulation 2006; 113:1564.</a></li><li><a class="nounderline abstract_t">Blacher J, Lailler G, Gabet A, et al. Acute coronary syndrome during pregnancy and postpartum in France: the nationwide CONCEPTION study. Am J Obstet Gynecol MFM 2023; 5:100781.</a></li><li><a class="nounderline abstract_t">Smilowitz NR, Gupta N, Guo Y, et al. Acute Myocardial Infarction During Pregnancy and the Puerperium in the United States. Mayo Clin Proc 2018; 93:1404.</a></li><li><a class="nounderline abstract_t">Ladner HE, Danielsen B, Gilbert WM. Acute myocardial infarction in pregnancy and the puerperium: a population-based study. Obstet Gynecol 2005; 105:480.</a></li><li><a class="nounderline abstract_t">Roos-Hesselink JW, Duvekot JJ, Thorne SA. Pregnancy in high risk cardiac conditions. Heart 2009; 95:680.</a></li><li><a class="nounderline abstract_t">Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. Ann Intern Med 1996; 125:751.</a></li><li><a class="nounderline abstract_t">Elkayam U, Jalnapurkar S, Barakkat MN, et al. Pregnancy-associated acute myocardial infarction: a review of contemporary experience in 150 cases between 2006 and 2011. Circulation 2014; 129:1695.</a></li><li><a class="nounderline abstract_t">Hayes SN, Kim ESH, Saw J, et al. Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association. Circulation 2018; 137:e523.</a></li><li><a class="nounderline abstract_t">Petitti DB, Sidney S, Quesenberry CP Jr, Bernstein A. Incidence of stroke and myocardial infarction in women of reproductive age. Stroke 1997; 28:280.</a></li><li><a class="nounderline abstract_t">Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. J Am Coll Cardiol 2008; 52:171.</a></li><li><a class="nounderline abstract_t">Mather PJ, Hansen CL, Goldman B, et al. Postpartum multivessel coronary dissection. J Heart Lung Transplant 1994; 13:533.</a></li><li><a class="nounderline abstract_t">Havakuk O, Goland S, Mehra A, Elkayam U. Pregnancy and the Risk of Spontaneous Coronary Artery Dissection: An Analysis of 120 Contemporary Cases. Circ Cardiovasc Interv 2017; 10.</a></li><li><a class="nounderline abstract_t">Nallamothu BK, Saint M, Saint S, Mukherjee D. Clinical problem-solving. Double jeopardy. N Engl J Med 2005; 353:75.</a></li><li><a class="nounderline abstract_t">Shade GH Jr, Ross G, Bever FN, et al. Troponin I in the diagnosis of acute myocardial infarction in pregnancy, labor, and post partum. Am J Obstet Gynecol 2002; 187:1719.</a></li><li><a class="nounderline abstract_t">Chaithiraphan V, Gowda RM, Khan IA, Reimers CD. Peripartum acute myocardial infarction: management perspective. Am J Ther 2003; 10:75.</a></li><li><a class="nounderline abstract_t">Ascarelli MH, Grider AR, Hsu HW. Acute myocardial infarction during pregnancy managed with immediate percutaneous transluminal coronary angioplasty. Obstet Gynecol 1996; 88:655.</a></li><li><a class="nounderline abstract_t">Sanchez-Ramos L, Chami YG, Bass TA, et al. Myocardial infarction during pregnancy: management with transluminal coronary angioplasty and metallic intracoronary stents. Am J Obstet Gynecol 1994; 171:1392.</a></li><li><a class="nounderline abstract_t">Cauldwell M, Johnson M, Jahangiri M, Roos-Hesselink J. Cardiac interventions and cardiac surgery and pregnancy. Int J Cardiol 2019; 276:43.</a></li><li class="breakAll">Cardiac Problems in Pregnancy, 3rd, Elkayam U, Gleicher N (Eds), Wiley-Liss, New York 1998.</li><li><a class="nounderline abstract_t">Halpern DG, Weinberg CR, Pinnelas R, et al. Use of Medication for Cardiovascular Disease During Pregnancy: JACC State-of-the-Art Review. J Am Coll Cardiol 2019; 73:457.</a></li><li><a class="nounderline abstract_t">Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. CLASP collaborative group. Br J Obstet Gynaecol 1995; 102:861.</a></li><li><a class="nounderline abstract_t">Hauth JC, Goldenberg RL, Parker CR Jr, et al. Low-dose aspirin: lack of association with an increase in abruptio placentae or perinatal mortality. Obstet Gynecol 1995; 85:1055.</a></li><li><a class="nounderline abstract_t">Lees CC, Lojacono A, Thompson C, et al. Glyceryl trinitrate and ritodrine in tocolysis: an international multicenter randomized study. GTN Preterm Labour Investigation Group. Obstet Gynecol 1999; 94:403.</a></li><li><a class="nounderline abstract_t">Duan L, Ng A, Chen W, et al. β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies. JAMA Intern Med 2017; 177:885.</a></li><li><a class="nounderline abstract_t">Rubin PC. Current concepts: beta-blockers in pregnancy. N Engl J Med 1981; 305:1323.</a></li><li><a class="nounderline abstract_t">Butters L, Kennedy S, Rubin PC. Atenolol in essential hypertension during pregnancy. BMJ 1990; 301:587.</a></li><li><a class="nounderline abstract_t">Yarrington CD, Valente AM, Economy KE. Cardiovascular Management in Pregnancy: Antithrombotic Agents and Antiplatelet Agents. Circulation 2015; 132:1354.</a></li><li><a class="nounderline abstract_t">Nana M, Morgan H, Moore S, et al. Antiplatelet therapy in pregnancy: A systematic review. Pharmacol Res 2021; 168:105547.</a></li><li><a class="nounderline abstract_t">Costantine MM, Cleary K, Eunice Kennedy Shriver National Institute of Child Health and Human Development Obstetric--Fetal Pharmacology Research Units Network. Pravastatin for the prevention of preeclampsia in high-risk pregnant women. Obstet Gynecol 2013; 121:349.</a></li><li><a class="nounderline abstract_t">Henck JW, Craft WR, Black A, et al. Pre- and postnatal toxicity of the HMG-CoA reductase inhibitor atorvastatin in rats. Toxicol Sci 1998; 41:88.</a></li><li><a class="nounderline abstract_t">Schumacher B, Belfort MA, Card RJ. Successful treatment of acute myocardial infarction during pregnancy with tissue plasminogen activator. Am J Obstet Gynecol 1997; 176:716.</a></li><li><a class="nounderline abstract_t">Roberts DH, Rodrigues EA, Ramsdale DR. Postpartum acute myocardial infarction successfully treated with intravenous streptokinase--a case report. Angiology 1993; 44:570.</a></li><li><a class="nounderline abstract_t">Turrentine MA, Braems G, Ramirez MM. Use of thrombolytics for the treatment of thromboembolic disease during pregnancy. Obstet Gynecol Surv 1995; 50:534.</a></li><li><a class="nounderline abstract_t">Cincotta RB, Davis SM, Gerraty RP, Thomson KR. Thrombolytic therapy for basilar artery thrombosis in the puerperium. Am J Obstet Gynecol 1995; 173:967.</a></li><li><a class="nounderline abstract_t">Fagher B, Ahlgren M, Astedt B. Acute massive pulmonary embolism treated with streptokinase during labor and the early puerperium. Acta Obstet Gynecol Scand 1990; 69:659.</a></li><li><a class="nounderline abstract_t">Hall RJ, Young C, Sutton GC, Cambell S. Treatment of acute massive pulmonary embolism by streptokinase during labour and delivery. Br Med J 1972; 4:647.</a></li><li><a class="nounderline abstract_t">Pombar X, Strassner HT, Fenner PC. Pregnancy in a woman with class H diabetes mellitus and previous coronary artery bypass graft: a case report and review of the literature. Obstet Gynecol 1995; 85:825.</a></li><li><a class="nounderline abstract_t">Vinatier D, Virelizier S, Depret-Mosser S, et al. Pregnancy after myocardial infarction. Eur J Obstet Gynecol Reprod Biol 1994; 56:89.</a></li><li><a class="nounderline abstract_t">Frenkel Y, Barkai G, Reisin L, et al. Pregnancy after myocardial infarction: are we playing safe? Obstet Gynecol 1991; 77:822.</a></li><li><a class="nounderline abstract_t">Jaworski C, Mariani JA, Wheeler G, Kaye DM. Cardiac complications of thoracic irradiation. J Am Coll Cardiol 2013; 61:2319.</a></li><li><a class="nounderline abstract_t">Burchill LJ, Lameijer H, Roos-Hesselink JW, et al. Pregnancy risks in women with pre-existing coronary artery disease, or following acute coronary syndrome. Heart 2015; 101:525.</a></li><li><a class="nounderline abstract_t">Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018; 39:3165.</a></li><li><a class="nounderline abstract_t">Mehta LS, Warnes CA, Bradley E, et al. Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association. Circulation 2020; 141:e884.</a></li></ol></div><div id="topicVersionRevision">Topic 89 Version 37.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22291121" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Annual summary of vital statistics: 2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34668401" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Changing Incidence and Mechanism of Pregnancy-Associated Myocardial Infarction in the State of California.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16534011" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Acute myocardial infarction in pregnancy: a United States population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36273812" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Acute coronary syndrome during pregnancy and postpartum in France: the nationwide CONCEPTION study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30031555" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Acute Myocardial Infarction During Pregnancy and the Puerperium in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15738011" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Acute myocardial infarction in pregnancy and the puerperium: a population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19329725" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Pregnancy in high risk cardiac conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8929010" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Acute myocardial infarction associated with pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24753549" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Pregnancy-associated acute myocardial infarction: a review of contemporary experience in 150 cases between 2006 and 2011.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29472380" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9040675" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Incidence of stroke and myocardial infarction in women of reproductive age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18617065" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Acute myocardial infarction associated with pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8061031" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Postpartum multivessel coronary dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28302642" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Pregnancy and the Risk of Spontaneous Coronary Artery Dissection: An Analysis of 120 Contemporary Cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16000358" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Clinical problem-solving. Double jeopardy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12501092" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Troponin I in the diagnosis of acute myocardial infarction in pregnancy, labor, and post partum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12522527" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Peripartum acute myocardial infarction: management perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8841241" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Acute myocardial infarction during pregnancy managed with immediate percutaneous transluminal coronary angioplasty.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7977558" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Myocardial infarction during pregnancy: management with transluminal coronary angioplasty and metallic intracoronary stents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30287057" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Cardiac interventions and cardiac surgery and pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30287057" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Cardiac interventions and cardiac surgery and pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30704579" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Use of Medication for Cardiovascular Disease During Pregnancy: JACC State-of-the-Art Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8534620" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Low dose aspirin in pregnancy and early childhood development: follow up of the collaborative low dose aspirin study in pregnancy. CLASP collaborative group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7770254" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Low-dose aspirin: lack of association with an increase in abruptio placentae or perinatal mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10472868" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Glyceryl trinitrate and ritodrine in tocolysis: an international multicenter randomized study. GTN Preterm Labour Investigation Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28418448" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6117014" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Current concepts: beta-blockers in pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2242456" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Atenolol in essential hypertension during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26438768" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Cardiovascular Management in Pregnancy: Antithrombotic Agents and Antiplatelet Agents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33716166" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Antiplatelet therapy in pregnancy: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23344286" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Pravastatin for the prevention of preeclampsia in high-risk pregnant women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9520344" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Pre- and postnatal toxicity of the HMG-CoA reductase inhibitor atorvastatin in rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9077638" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Successful treatment of acute myocardial infarction during pregnancy with tissue plasminogen activator.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8328686" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Postpartum acute myocardial infarction successfully treated with intravenous streptokinase--a case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7566831" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Use of thrombolytics for the treatment of thromboembolic disease during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7573284" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Thrombolytic therapy for basilar artery thrombosis in the puerperium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2094153" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Acute massive pulmonary embolism treated with streptokinase during labor and the early puerperium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4539533" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Treatment of acute massive pulmonary embolism by streptokinase during labour and delivery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7724126" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Pregnancy in a woman with class H diabetes mellitus and previous coronary artery bypass graft: a case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7805973" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Pregnancy after myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2030850" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Pregnancy after myocardial infarction: are we playing safe?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23583253" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Cardiac complications of thoracic irradiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25564557" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Pregnancy risks in women with pre-existing coronary artery disease, or following acute coronary syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30165544" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32362133" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Cardiovascular Considerations in Caring for Pregnant Patients: A Scientific Statement From the American Heart Association.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
